• Mashup Score: 0

    E arlier this year, we asked you, our readers, for nominations for our inaugural 40 Under 40 list. The goal was to highlight the next generation of ophthalmology: 40 ophthalmologists under 40 years old who have achieved excellence in their field. You responded with more than 100 nominations, detailing the efforts by many young surgeons in research, innovation, leadership, teaching, entrepreneurship, academics, global health and more. Our selection committee voted on the nominees and whittled down the

    Tweet Tweets with this article
    • This week, we highlight @yasha_modi, director of Tele-Retina at @nyulangone where he is also an associate professor of ophthalmology specializing in retinal disease, uveitis and vitreoretinal surgery. https://t.co/JPKiT5FDpv #uveitis #vitreoretinalsurgery #retina #ophthalmology https://t.co/ovNLRUfxZm

  • Mashup Score: 0

    The Ophthalmology Journal podcast reviews research articles, editorials, and more from the Academy’s journal family: Ophthalmology, Ophthalmology Retina, Ophthalmology Glaucoma

    Tweet Tweets with this article
    • What are the risk factors for patients developing pseudophakic cystoid #macular edema (pCME) after #cataract surgery? In the latest episode of the #OphthalmologyJournal #podcast, @edmundtsuiMD & Dr. Ahmed B. Sallam discuss the risk of pCME. #uveitis https://t.co/soO5PY0hRF https://t.co/9Z8dtNqnE6

  • Mashup Score: 1
    ACR on Air Podcast - 8 month(s) ago

    Listen to ACR on Air, the official podcast of the American College of Rheumatology, for information on rheumatic disease research, solutions for practice management issues, legislative policies impacting patient care, and more.

    Tweet Tweets with this article
    • To help us bring #uveitis into focus is guest Dr. James T. Rosenbaum, who explains what uveitis is, how it’s treated, & when patients with #rheum disease should seek additional treatment from an #ophthalmologist. Tune in & learn more → https://t.co/TU8q0CZGRm https://t.co/1kHbwuCqG1

  • Mashup Score: 7

    Objective To evaluate tocilizumab (TCZ) efficacy in patients with refractory Behçet disease (BD). Methods This is a multicenter study of 30 patients fulfilling the international criteria for BD and treated with TCZ at different European referral centers. The clinical response was evaluated at 6 months from TCZ initiation. Results Ninety percent of patients with BD were refractory or intolerant…

    Tweet Tweets with this article
    • Research Article Tocilizumab in Behçet Disease: A Multicenter Study of 30 Patients 📰 https://t.co/jBmtWqsmih #behçetdisease #tocilizumab #uveitis https://t.co/CEoaptWGre